1 / 22

For Discussion and Consultation: Our Ideas for “Health Impact Accounts”

For Discussion and Consultation: Our Ideas for “Health Impact Accounts”. Dr. Armin H. Fidler Lead Adviser, Health Policy and Strategy The World Bank Group Brussels, February 7, 2012. Outline. Background Rationale Challenges to current approach The need for Health Impact Accounts

belle
Download Presentation

For Discussion and Consultation: Our Ideas for “Health Impact Accounts”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. For Discussion and Consultation: Our Ideas for “Health Impact Accounts” Dr. Armin H. Fidler Lead Adviser, Health Policy and Strategy The World Bank Group Brussels, February 7, 2012

  2. Outline Background Rationale Challenges to current approach The need for Health Impact Accounts Principles for estimates Next steps

  3. Significant increase in DHA but challenges to sustain • Recent scale-up of funding for health from domestic and donor sources • Several reasons behind expansion of donor interest in health • Following 2008 global fiscal crisis, donor countries are increasingly demanding clear evidence on the impact of their investment

  4. Demand from donors and tax-payers for funding organizations to demonstrate results Multilaterals, in the past, have had two options to respond to demand for evidence: 1. Ex-ante analyses of global costs and health benefits • Although ex-ante analyses of global costs and health benefits have figured prominently in advocacy for global health programs7 these efforts are often based on the limited evidence-base available prior to major program scale-up. 2. Ex-post evaluations of investments. • These results are often delivered long after project is completed and methods are not applicable to on-going review

  5. A recent effort to communicate results: “Lives Saved” 3. Calculation of ‘lives saved’ to provide rapid estimates based on likely benefits from expenditures • Provide a timely, compelling, and perceived as meaningful metrics for impact of investments in the health sector • While current Lives Saved approach should be applauded, it does not take into account the entire health system when measuring outcomes • Additionally, these results, while faster, face significant methodological and data challenges • Due to current challenges, the World Bank has decided to revise (“upgrade”) its Lives saved methodology.

  6. World Bank – IHME Collaboration on next Generation of Lives Saved The World Bank has partnered with IHME to: • Preserve the benefits of initial Lives Saved approach with timely, meaningful and compelling information with comprehensible estimates on the likely impact of health investments • Create a framework for the next generation of investment impact accountability methodology • Improve metrics that take into account all key components of the health system that contribute to success

  7. Rationale • Demand for metrics that convey the impact of DAH in a compelling, digestible and timely manner • While current Lives Saved approach should be applauded, it does not take into account the entire health system when measuring outcomes

  8. Lives Saved Approach: Key Challenges • Current Lives Saved approach diminishes the importance of the role of Health System Investments • Most approaches attribute lives saved to consumables or commodities • They neglect to take into account that the effectiveness of such consumables and commodities depends upon their reaching patients and users • Many components of the delivery-value-chain may be involved in this

  9. Currently, Impact linked mostly with commodity Malaria treatment Purchased Malaria Drug Efficient Warehousing and wholesale distribution Child Treated

  10. But, effectiveness of treatment requires a well functioning malaria treatment value chain Global R & D; country level quality control and licensing Malaria treatment Robust and Efficient Procurement Purchased Malaria Drug Efficient Warehousing and wholesale distribution Information and HH demand side mechanisms Clinic, and trained health worker Motivated and efficient Health Worker, diagnosis and treatment Child Treated

  11. Key priority disease value chains share same critical components. Need for System approach to strengthen them Interventions Vertical HIV Transmission Prevention Micro Nutrients Supplement During Pregnancy (Vit A) Malaria Prevention through Bed-Net Syst. Component Global R & D; country level quality control and licensing Global R & D; country level quality control and licensing Global R & D; country level quality control and licensing Regulatory Capacity (Stewardship) Robust and Efficient Procurement Robust and Efficient Procurement Robust and Efficient Procurement Procurement Capacity Purchased Micro Nutrient Purchased Malaria Drug Purchased ARV Consumable or commodity Efficient Warehousing and wholesale distribution Efficient Warehousing and wholesale distribution Efficient Warehousing and wholesale distribution Logistics and Distribution Information and HH demand side mechanisms Information and HH demand side mechanisms Information and HH demand side mechanisms Communications; CCTs, Health Insurance Clinic, and trained health worker Clinic, and trained health worker Clinic, Laboratory and trained health worker Worker training, hiring and retention; Infrastructure Motivated and efficient Health Worker, prescription and provision Motivated and efficient Health Worker, diagnosis and treatment Motivated and efficient Health Worker, diagnosis and treatment Provider Payment Mechanisms Child Treated Mother Consuming MN Mother Treated

  12. Lives Saved Approach: Key Challenges • Health Impact from Investments in Other Sectors are underestimated • For example, the impact of programs on environmental pollution, transportation, and indoor air pollution are not yet assessed • Currently included: education for young girls, road safety, water and sanitation Source: This is where your source copy goes.

  13. Methodological Limitations • Potential for double-counting • Current Live Saved methodologies have the potential for the same life saved to be counted multiple times by different donor organizations • Heterogeneity in the timing of benefits • Deaths prevented through one intervention can be nearly instantaneous while for others it may be in years to come • Efficacy versus effectiveness • Most information currently used comes from randomized clinical trials, but an extensive literature demonstrates that due to enhanced provider effort and exclusion criteria used in RCTs, the likely benefits in most scaled-up programs will be smaller

  14. Moving Forward • To sustain investments in global health • critical to quantify the likely health benefits of the current investment portfolios • communicate that impact in a timely and compelling manner. • One way: “Health Impact Accounts” HIAs are a systematic assessment of the health impact of an investment portfolio compared to the counterfactual

  15. 1. Assess all investments in terms of critical value chains • Improved health from investment comes through the delivery of interventions to improve health • First step to understanding investment impact is identifying the critical value chains involved in the implementation

  16. 2. Assess national changes in inputs and effective coverage for a value-chain • HIA must take into account all actors influencing a value chain in a country • This requires the most information possible on NHAs, but in their absence, the projection of a secular trend in coverage that would have occurred without donor investments would suffice

  17. Bednets Example Hypothetical case of the trend in investment and coverage for a value-chain

  18. 3. Allocate national changes in effective coverage to components and by investors in value-chain • If one organization is investing in cold chains and health information and the other in financing vaccines, the overall changes in immunization coverage should be allocated accordingly

  19. 3. Allocate national changes in effective coverage to components and by investors in value-chain • If there is clear evidence about the pay-off from different types of investments this should be taken into account • If there is clear evidence that one donor is more efficient that others in investing DAH on value chain components, this should be taken into account • Otherwise, all donors should be considered equally efficient

  20. 4. Estimate health impact from changes in coverage with evidence including national trends in health outcomes • The strongest possible effort should be made to map the path for intervention to health gain • Take into account both demand and supply side factors to identify gap between efficacy and effectiveness

  21. 5. Health impact should be disaggregated into time periods and different metrics • Different users of the HIA may want to understand when benefits should occur and what the magnitude of the gain is for the affected population

  22. Next Steps • Demonstrate feasibility of proposed approach at a global scale for selected value chain both in and out of the health sector • Develop strategic messaging of new health impact accounting to explain, justify and enhance credibility • Expand analysis beyond World Bank

More Related